New drugs for asthma, allergy and COPD:

This book provides a state-of-the-art account by academic respiratory physicians and senior pharmaceutical industry personnel on the development of new drugs for asthma, allergy and COPD. It contains 80 chapters of highly condensed information, presented in an attractive, reader-friendly format with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Hansel, Trevor T. 1956- (HerausgeberIn), Barnes, Peter J. (HerausgeberIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Basel Karger 2001
Schriftenreihe:Progress in respiratory research Vol. 31
Schlagworte:
Online-Zugang:BFB01
BSB01
BTW01
EUV01
FAN01
FAW01
FFW01
FHI01
FHM01
FHN01
FHR01
FKE01
FNU01
FWS01
FWS02
GEM01
LCO01
SAB01
SAM01
SBG01
SBR01
SND01
TUM01
UBA01
UBG01
UBM01
UBR01
UBT01
UBW01
UER01
UPA01
Volltext
Zusammenfassung:This book provides a state-of-the-art account by academic respiratory physicians and senior pharmaceutical industry personnel on the development of new drugs for asthma, allergy and COPD. It contains 80 chapters of highly condensed information, presented in an attractive, reader-friendly format with much use of tables, figures and diagrams. In addition to summarizing the diverse range of current approaches, this handbook also looks into the future, considering many topics that are promising, but have only emerged in the last few years. Developments within established drug categories such as beta-2-agonists, steroids and leukotriene antagonists are also reviewed.Never before has a single book brought together so many pharmaceutical drug developers sharing their experience on such a wide range of respiratory topics!
Beschreibung:the inside story of drug development
Beschreibung:1 Online-Ressource (X, 389 Seiten) Illustrationen, Diagramme
ISBN:9783318004243